WT1 and pancreatic neoplasm: In addition, epitope peptides that are able to induce strong and specific CTLs against WT1 antigens have been identified, and a retrospective study of a dendritic cell vaccine loaded with WT1 peptides in combination with chemotherapy in patients with advanced pancreatic cancer suggested that survival was prolonged without serious adverse events [16].